Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 3
2014 3
2015 4
2016 6
2017 1
2018 2
2019 4
2020 12
2021 16
2022 15
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update.
Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landewé RBM, Van den Bosch FE, Boteva B, Bremander A, Carron P, Ciurea A, van Gaalen FA, Géher P, Gensler L, Hermann J, de Hooge M, Husakova M, Kiltz U, López-Medina C, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compán V, Nissen MJ, Pimentel-Santos FM, Poddubnyy D, Proft F, Rudwaleit M, Telkman M, Zhao SS, Ziade N, van der Heijde D. Ramiro S, et al. Among authors: ortolan a. Ann Rheum Dis. 2023 Jan;82(1):19-34. doi: 10.1136/ard-2022-223296. Epub 2022 Oct 21. Ann Rheum Dis. 2023. PMID: 36270658 Free article.
Erosive hand osteoarthritis: latest findings and outlook.
Favero M, Belluzzi E, Ortolan A, Lorenzin M, Oliviero F, Doria A, Scanzello CR, Ramonda R. Favero M, et al. Among authors: ortolan a. Nat Rev Rheumatol. 2022 Mar;18(3):171-183. doi: 10.1038/s41584-021-00747-3. Epub 2022 Feb 1. Nat Rev Rheumatol. 2022. PMID: 35105980 Review.
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis.
Webers C, Ortolan A, Sepriano A, Falzon L, Baraliakos X, Landewé RBM, Ramiro S, van der Heijde D, Nikiphorou E. Webers C, et al. Among authors: ortolan a. Ann Rheum Dis. 2023 Jan;82(1):130-141. doi: 10.1136/ard-2022-223298. Epub 2022 Oct 21. Ann Rheum Dis. 2023. PMID: 36270657 Review.
Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.
Ortolan A, Webers C, Sepriano A, Falzon L, Baraliakos X, Landewé RB, Ramiro S, van der Heijde D, Nikiphorou E. Ortolan A, et al. Ann Rheum Dis. 2023 Jan;82(1):142-152. doi: 10.1136/ard-2022-223297. Epub 2022 Oct 19. Ann Rheum Dis. 2023. PMID: 36261247 Review.
Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment.
Costa L, Ramonda R, Ortolan A, Favero M, Foti R, Visalli E, Rossato M, Cacciapaglia F, Lapadula G, Scarpa R. Costa L, et al. Among authors: ortolan a. Clin Rheumatol. 2019 Sep;38(9):2355-2362. doi: 10.1007/s10067-019-04663-6. Epub 2019 Jun 28. Clin Rheumatol. 2019. PMID: 31264033 Review.
Unusual ossification: psoriatic arthritis or not?
Ramonda R, Vio S, Ortolan A, Lorenzin M. Ramonda R, et al. Among authors: ortolan a. Clin Exp Rheumatol. 2021 Mar-Apr;39(2):439. doi: 10.55563/clinexprheumatol/m2qah9. Epub 2020 Nov 7. Clin Exp Rheumatol. 2021. PMID: 33200743 Free article. No abstract available.
Serological markers of erosive hand osteoarthritis.
Ramonda R, Lorenzin M, Modesti V, Campana C, Ortolan A, Frallonardo P, Punzi L. Ramonda R, et al. Among authors: ortolan a. Eur J Intern Med. 2013 Jan;24(1):11-5. doi: 10.1016/j.ejim.2012.10.002. Epub 2012 Oct 25. Eur J Intern Med. 2013. PMID: 23102569 Review.
60 results